In view of these results, we have asked the question whether EGR-1 has any role in chemoresistance to cisplatin or other drugs in glioma primary cells in vitro, and if this is related to the p53 status of the tumor or to other genes whose activity is required for the proper cytotoxic response. The gene discussed is TP53; the disease is glioma.